AngioDynamics, Inc. (ANGO) Short Interest Update

AngioDynamics, Inc. (NASDAQ:ANGO) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,310,989 shares, an increase of 3.9% from the March 15th total of 1,261,487 shares. Based on an average daily volume of 246,783 shares, the short-interest ratio is presently 5.3 days.

Shares of AngioDynamics (NASDAQ:ANGO) opened at 15.73 on Friday. The firm has a 50-day moving average price of $16.60 and a 200-day moving average price of $16.64. The stock’s market cap is $578.55 million. AngioDynamics has a 1-year low of $11.52 and a 1-year high of $18.18.

AngioDynamics (NASDAQ:ANGO) last released its quarterly earnings data on Thursday, March 30th. The medical instruments supplier reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.04. AngioDynamics had a positive return on equity of 4.87% and a negative net margin of 7.91%. The firm earned $85.60 million during the quarter, compared to the consensus estimate of $88.29 million. During the same period last year, the business posted $0.15 EPS. AngioDynamics’s quarterly revenue was down 2.1% on a year-over-year basis. Equities analysts forecast that AngioDynamics will post $0.70 EPS for the current year.

In other AngioDynamics news, major shareholder Avista Capital Partners Gp, Ll sold 2,350,000 shares of the stock in a transaction on Wednesday, April 12th. The stock was sold at an average price of $16.00, for a total value of $37,600,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.88% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in ANGO. Spark Investment Management LLC increased its position in AngioDynamics by 44.4% in the third quarter. Spark Investment Management LLC now owns 138,500 shares of the medical instruments supplier’s stock valued at $2,429,000 after buying an additional 42,600 shares during the last quarter. State of Tennessee Treasury Department increased its position in AngioDynamics by 10.0% in the third quarter. State of Tennessee Treasury Department now owns 22,865 shares of the medical instruments supplier’s stock valued at $401,000 after buying an additional 2,075 shares during the last quarter. Municipal Employees Retirement System of Michigan increased its position in AngioDynamics by 7.3% in the third quarter. Municipal Employees Retirement System of Michigan now owns 6,330 shares of the medical instruments supplier’s stock valued at $111,000 after buying an additional 430 shares during the last quarter. New York State Common Retirement Fund increased its position in AngioDynamics by 32.6% in the third quarter. New York State Common Retirement Fund now owns 175,660 shares of the medical instruments supplier’s stock valued at $3,081,000 after buying an additional 43,210 shares during the last quarter. Finally, BlackRock Fund Advisors increased its position in AngioDynamics by 14.2% in the third quarter. BlackRock Fund Advisors now owns 2,051,381 shares of the medical instruments supplier’s stock valued at $35,981,000 after buying an additional 255,064 shares during the last quarter. 79.52% of the stock is owned by institutional investors.

A number of analysts have weighed in on ANGO shares. Cantor Fitzgerald reiterated a “buy” rating and issued a $19.00 target price on shares of AngioDynamics in a research note on Tuesday, December 27th. Canaccord Genuity reiterated a “hold” rating and issued a $17.50 target price on shares of AngioDynamics in a research note on Monday, January 23rd. Barclays PLC started coverage on AngioDynamics in a research note on Wednesday, February 8th. They issued an “equal weight” rating and a $17.00 target price on the stock. Finally, Zacks Investment Research lowered AngioDynamics from a “buy” rating to a “hold” rating in a research note on Wednesday, January 11th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. AngioDynamics currently has an average rating of “Buy” and an average target price of $18.75.

ILLEGAL ACTIVITY WARNING: “AngioDynamics, Inc. (ANGO) Short Interest Update” was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.chaffeybreeze.com/2017/04/21/angiodynamics-inc-ango-short-interest-update.html.

AngioDynamics Company Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

5 Day Chart for NASDAQ:ANGO

Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply